Cravath, Swaine & Moore is serving as legal counsel to Johnson & Johnson, while Skadden is serving as legal counsel to Ambrx Biopharma on the transaction....
Johnson & Johnson’s Acquisition of Ambrx Biopharma
Eli Lilly’s $1.4 Billion Acquisition of POINT Biopharma
Kirkland & Ellis LLP is acting as legal counsel to Lilly, while Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal counsel to POINT...
Wendel Group and Colibri Group’s $1 Billion Acquisition of Financial Services Segment From Adtalem Global Education
Finn Dixon & Herling acted as legal counsel to Colibri and Gridiron, while Kirkland & Ellis, as Wendel’s legal advisor. Skadden, Arps, Slate, Meagher & Flom...
AspenTech’s Merger With Emerson Electric Co.’s
Simpson Thacher advised JPMorgan as financial advisor on the deal, while Davis Polk advised Emerson. Skadden, Arps, Slate, Meagher & Flom advised AspenTech. Aspen Technology, Inc....
Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
Alcon’s Acquisition of U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
Skadden, Arps, Slate, Meagher & Flom LLP advised Alcon on the deal. Alcon, the global leader in eye care dedicated to helping people see brilliantly, has...